The environment, epigenome, and asthma

Abstract

Asthma prevalence has been on the increase, especially in North America compared with other continents. However, the prevalence of asthma differs worldwide, and in many countries the prevalence is stable or decreasing. This highlights the influence of environmental exposures, such as allergens, air pollution, and the environmental microbiome, on disease etiology and pathogenesis. The epigenome might provide the unifying mechanism that translates the influence of environmental exposures to changes in gene expression, respiratory epithelial function, and immune cell skewing that are hallmarks of asthma. In this review we will introduce the concept of the environmental epigenome in asthmatic patients, summarize previous publications of relevance to this field, and discuss future directions.

PDF (1 MB)

Full Text

 

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Weekly Clinical Case Challenge from Derm101. What is your diagnosis? https://t.co/MKRIih9ePL https://t.co/tfv97WusKJ
55mreplyretweetfavorite
Interasma RT @Aller_MD: Top story: WORLD ALLERGY CONGRESS | WAC2019 - WORLD ALLERGY CONGRESS https://t.co/LR5vgHROK7, see more https://t.co/jgCeENQuZt
55mreplyretweetfavorite
Interasma RT @Aller_MD: “Global Temperature Affects Dengue” https://t.co/ICMfeeMBIj
55mreplyretweetfavorite
Interasma RT @Aller_MD: “The Risks and Benefits of Expedited Drug Reviews. The US Food and Drug Administration (FDA) oversees several programs that e…
55mreplyretweetfavorite
Interasma RT @Aller_MD: “Health Data and Privacy in the Digital Era” https://t.co/Q3bND39qKb https://t.co/VXukVQi7B7
55mreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma